Cenobamate in adult patients with epilepsy and intellectual disability

In adult PWE and intellectual disability, cenobamate is similarly efficacious and tolerated as in patients without ID.

Authors

Institutions

Publication Details

Journal
Seizure
Published
2025-11-23
DOI
https://doi.org/10.1016/j.seizure.2025.11.017
Citations
1
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cenobamate in adult patients with epilepsy and intellectual disability

Martin Holtkamp, David Steinbart, Anja Grimmer, Rebekka Lehmann et al.
1 citations
Seizure
Epilepsy research and treatment
1.47
article

Cenobamate in adult patients with epilepsy and intellectual disability

Martin Holtkamp, David Steinbart, Anja Grimmer, Rebekka Lehmann, Rebekka Geelhaar
article en
1 citations

Abstract

In adult PWE and intellectual disability, cenobamate is similarly efficacious and tolerated as in patients without ID.

SeizureVol. 134
Humboldt-Universität zu Berlin (DE), Einstein Center for Neurosciences Berlin (DE)
Openalex Percentile: Top 13%
Epilepsy research and treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cenobamate in adult patients with epilepsy and intellectual disability — Martin Holtkamp, David Steinbart, et al. · Seizure (2025) | TGRS Research Map | TGRS